Future Health ESG Corp. Common stock
FHLT
FHLT was delisted on the 20th of May, 2024.
1 hedge funds and large institutions have $49.1K invested in Future Health ESG Corp. Common stock in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 7 closing their positions.
88% less funds holding
Funds holding: 8 → 1 (-7)
100% less capital invested
Capital invested by funds: $10M → $49.1K (-$9.95M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$8.85M |
| 2 |
Walleye Capital
New York
|
-$686K |
| 3 |
Walleye Trading
New York
|
-$386K |
| 4 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$16.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11 |
FHLT Hedge Fund Activity: Q2 2024 in Review
1 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Future Health ESG Corp. Common stock (FHLT) for Q2 2024, worth a combined $49.1K — down 100% from $10M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of FHLT and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $8.85M sold.
- 1 institutional investor held Future Health ESG Corp. Common stock (FHLT) as of Q2 2024, down from 8 in Q1 2024.
- Funds reported $49.1K of Future Health ESG Corp. Common stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Future Health ESG Corp. Common stock positions in Q2 2024 and 7 closed out, a net change of -7 holders.
- The largest Future Health ESG Corp. Common stock seller in Q2 2024 was Polar Asset Management Partners, an estimated $8.85M sold.
Based on aggregated 13F filings for Q2 2024.